Mice with a version of osteoarthritis experienced symptom relief after expression of a protein targeting a stem-cell receptor ...

Researchers found no significant differences in surgical outcomes or follow-up between housed and unhoused patients with ...

Johnson & Johnson MedTech (NYSE:JNJ) today announced a strategic co-promotion agreement with Pacira BioSciences.

SGLT2 inhibitors, compared with GLP-1 RAs, were associated with lower risks for osteoarthritis and joint replacement surgery among patients with T2D.

Johnson & Johnson is partnering with Pacira BioSciences for osteoarthritis of the knee, according to a July 22 news release. The agreement adds Zilretta, an injectable osteoarthritis treatment, to ...

Romosozumab, used in osteoporosis treatment, may offer dual benefits by also reducing the risk for osteoarthritis, notably ...

Combining HA with PRP is synergistic, according to a new, well designed, randomized study of knee OA. But…pain relief, no ...

IL-1 is considered one of the key mediators involved in the pathogenesis of OA, causing inflammation, joint pain, and ...

The device has already completed a 12-week trial with a small group of users, who wore it for up to an hour a day, five to ...

Individuals with vs without knee, hip, or hand OA were associated with a significantly increased risk for sleep apnea.

Higher UPF-consumption was linked to worse knee OA outcomes among women, including higher pain scores, worse physical function, and thinner knee cartilage.

Some key factors which increased the risk of developing knee osteoarthritis included being overweight or obese, past knee ...